Deoxyribonucleic Acid Profiling Analysis of 40 Human Thyroid Cancer Cell Lines Reveals Cross-Contamination Resulting in Cell Line Redundancy and Misidentification

Mutations of the BRAF gene in human cancer

Davies, H., Bignell, G. R., Cox, C., Stephens, P., Edkins, S., Clegg, S., Teague, J., Woffendin, H., Garnett, M. J., Bottomley, W., et al. (2002) · Nature · doi:10.1038/nature00766 · Cited by 10,674

In Vitro Cultivation of Human Tumors: Establishment of Cell Lines Derived From a Series of Solid Tumors2

Giard, D. J., Aaronson, S. A., Todaro, G. J., Arnstein, P., Kersey, J. H., Dosik, H., & Parks, W. P. (1973) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/51.5.1417 · Cited by 2,336

High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma.

Kimura, E. T., Nikiforova, M. N., Zhu, Z., Knauf, J. A., Nikiforov, Y. E., & Fagin, J. A. (2003) · PubMed · Cited by 1,510

BRAF Mutations in Thyroid Tumors Are Restricted to Papillary Carcinomas and Anaplastic or Poorly Differentiated Carcinomas Arising from Papillary Carcinomas

Nikiforova, M. N., Kimura, E. T., Gandhi, M., Biddinger, P. W., Knauf, J. A., Basolo, F., Zhu, Z., Giannini, R., Salvatore, G., Fusco, A., et al. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030838 · Cited by 1,036

New Human Tumor Cell Lines

Fogh, J., & Trempe, G. (1975) · Springer eBooks · doi:10.1007/978-1-4757-1647-4_5 · Cited by 1,034

Molecular characterization of human prostate carcinoma cell lines

van Bokhoven, A., Varella‐Garcia, M., Korch, C. T., Johannes, W. U., Smith, E. E., Miller, H. L., Nordeen, S. K., Miller, G. J., & Lucia, M. S. (2003) · The Prostate · doi:10.1002/pros.10290 · Cited by 635

Clinical Implication of Hot SpotBRAFMutation, V599E, in Papillary Thyroid Cancers

Namba, H., Nakashima, M., Hayashi, T., Hayashida, N., Maeda, S., Rogounovitch, T., Ohtsuru, A., Saenko, V., Kanematsu, T., & Yamashita, S. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030305 · Cited by 532

Short tandem repeat profiling provides an international reference standard for human cell lines

Masters, J. R., Thomson, J. A., Daly-Burns, B., Reid, Y. A., Dirks, W. G., Packer, P., Toji, L. H., Ohno, T., Tanabe, H., Arlett, C. F., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.121616198 · Cited by 478

Phosphatidylinositide 3-kinase (PI3K) and PI3K-related kinase (PIKK) activity contributes to radioresistance in thyroid carcinomas

Burrows, N., Williams, J., Telfer, B. A., Resch, J., Valentine, H. R., Fitzmaurice, R. J., Eustace, A., Irlam, J. J., Rowling, E. J., Hoang‐Vu, C., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.11056 · Cited by 13

Imatinib increases oxygen delivery in extracellular matrix-rich but not in matrix-poor experimental carcinoma

Burmakin, M., van Wieringen, T., Olsson, P. O., Stuhr, L. E. B., Åhgren, A., Heldin, C., Reed, R. K., Rubin, K., & Hellberg, C. B. (2017) · Journal of Translational Medicine · doi:10.1186/s12967-017-1142-7 · Cited by 13

Sustained activation of the AKT/mTOR and MAP kinase pathways mediate resistance to the Src inhibitor, dasatinib, in thyroid cancer

Mishall, K. M., Beadnell, T. C., Kuenzi, B. M., Klimczak, D. M., Superti‐Furga, G., Rix, U., & Schweppe, R. E. (2017) · Oncotarget · doi:10.18632/oncotarget.20488 · Cited by 13

Inhibition of integrin αVβ6 changes fibril thickness of stromal collagen in experimental carcinomas

Olsson, P. O., Gustafsson, R., Salnikov, A. V., Göthe, M., Zeller, K. S., Friman, T., Baldetorp, B., Koopman, L. A., Weinreb, P. H., Violette, S. M., et al. (2018) · Cell Communication and Signaling · doi:10.1186/s12964-018-0249-7 · Cited by 13

Evodiamine in combination with histone deacetylase inhibitors has synergistic cytotoxicity in thyroid carcinoma cells

Kim, S. H., Kang, J. G., Kim, C. S., Ihm, S., Choi, M. G., & Lee, S. J. (2019) · Endocrine · doi:10.1007/s12020-019-01885-1 · Cited by 13

Targeting Epidermal Growth Factor Receptor 1 Signaling in Human Thyroid-Stimulating Hormone–Independent Thyroid Carcinoma FRO Cells Results in a More Chemosensitive and Less Angiogenic Phenotype

Landriscina, M., Piscazzi, A., Fabiano, A., Maddalena, F., Costantino, E., Farese, A., Bufo, P., & Cignarelli, M. (2009) · Thyroid · doi:10.1089/thy.2008.0355 · Cited by 13

Synthetic sulfoglycolipids targeting the serine–threonine protein kinase Akt

Costa, B., Dangate, M. S., Vetro, M., Donvito, G., Gabrielli, L., Amigoni, L., Cassinelli, G., Lanzi, C., Ceriani, M., GIOIA, L. D., et al. (2016) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2016.05.031 · Cited by 13

Natural Compounds Targeting MAPK, PI3K/Akt, and JAK/STAT Signaling in Papillary Thyroid Cancer

Carnazza, M. A., Yang, N., Tiwari, R. K., Geliebter, J., & Li, X.-M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262110498 · Cited by 12

Serine 897 Phosphorylation of EPHA2 Is Involved in Signaling of Oncogenic ERK1/2 Drivers in Thyroid Cancer Cells

Allocca, C., Cirafici, A. M., Laukkanen, M. O., & Castellone, M. D. (2020) · Thyroid · doi:10.1089/thy.2019.0728 · Cited by 12

Development and Characterization of a Differentiated Thyroid Cancer Cell Line Resistant to VEGFR-Targeted Kinase Inhibitors

Isham, C. R., Netzel, B. C., Bossou, A. R., Milosevic, D., Cradic, K. W., Grebe, S. K. G., & Bible, K. C. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2658 · Cited by 12

BET bromodomain inhibitor JQ1 modulates microRNA expression in thyroid cancer cells

Mio, C., Conzatti, K., Baldan, F., Allegri, L., Sponziello, M., Rosignolo, F., Russo, D., Filetti, S., & Damante, G. (2017) · Oncology Reports · doi:10.3892/or.2017.6152 · Cited by 12

Potent effects of roniciclib alone and with sorafenib against well-differentiated thyroid cancer

Lin, S., Lin, J., Hsueh, C., Chou, T., & Wong, R. J. (2018) · Endocrine Related Cancer · doi:10.1530/erc-18-0150 · Cited by 12

Evaluation of preclinical efficacy of everolimus and pasireotide in thyroid cancer cell lines and xenograft models

Owonikoko, T. K., Zhang, G., Lallani, S. B., Chen, Z., Martinson, D. E., Khuri, F. R., Lonial, S., Marcus, A. I., & Sun, S. (2019) · PLoS ONE · doi:10.1371/journal.pone.0206309 · Cited by 12

Targeting PLKs as a therapeutic approach to well-differentiated thyroid cancer

Lin, S., Lin, J., Yeh, C., Huang, Y., Chou, T., & Wong, R. J. (2019) · Endocrine Related Cancer · doi:10.1530/erc-18-0555 · Cited by 12

Interplay between thyroid cancer cells and macrophages: effects on IL-32 mediated cell death and thyroid cancer cell migration

Sloot, Y. J. E., Rabold, K., Ulas, T., de Graaf, D. M., Heinhuis, B., Händler, K., Schultze, J. L., Netea, M. G., Smit, J. W. A., Joosten, L. A. B., et al. (2019) · Cellular Oncology · doi:10.1007/s13402-019-00457-9 · Cited by 12

Magnetic Resonance Imaging for Translational Research in Oncology

Fiordelisi, M. F., Cavaliere, C., Auletta, L., Basso, L., & Salvatore, M. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8111883 · Cited by 12

Development of Novel Follicular Thyroid Cancer Models Which Progress to Poorly Differentiated and Anaplastic Thyroid Cancer

Caperton, C. O., Jolly, L. A., Massoll, N. A., Bauer, A. J., & Franco, A. T. (2021) · Cancers · doi:10.3390/cancers13051094 · Cited by 12

Thyroid tumors: novel insights from proteomic studies

Damante, G., Scaloni, A., & Tell, G. (2009) · Expert Review of Proteomics · doi:10.1586/epr.09.51 · Cited by 12

Cyclic AMP–Response Element Modulator Inhibits the Promoter Activity of the Sodium Iodide Symporter Gene in Thyroid Cancer Cells

Passon, N., Puppin, C., Lavarone, E., Bregant, E., Franzoni, A., Hershman, J. M., Fenton, M. S., D’Agostino, M. N., Durante, C., Russo, D., et al. (2012) · Thyroid · doi:10.1089/thy.2011.0360 · Cited by 12

A silver lining in cell line authentication: Short tandem repeat analysis of 1373 cases in China from 2010 to 2019

Gu, M., Yang, M., He, J., Xia, S., Zhang, Z., Wang, Y., Zheng, C., & Shen, C. (2022) · International Journal of Cancer · doi:10.1002/ijc.33789 · Cited by 11

Human telomerase reverse transcriptase in papillary thyroid cancer: gene expression, effects of silencing and regulation by BET inhibitors in thyroid cancer cells

Maggisano, V., Celano, M., Lepore, S. M., Sponziello, M., Rosignolo, F., Pecce, V., Verrienti, A., Baldan, F., Mio, C., Allegri, L., et al. (2019) · Endocrine · doi:10.1007/s12020-018-01836-2 · Cited by 11

Down-Modulation of Expression, or Dephosphorylation, of IG20/MADD in Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand–Resistant Thyroid Cancer Cells Makes Them Susceptible to Treatment with This Ligand

Li, L.-C., Jayarama, S., Pilli, T., Qian, L., Pacini, F., & Prabhakar, B. S. (2012) · Thyroid · doi:10.1089/thy.2012.0155 · Cited by 11

Cooperative effects of SAHA and VPA on NIS gene expression and proliferation of thyroid cancer cells

Puppin, C., Passon, N., Hershman, J. M., Filetti, S., Bulotta, S., Celano, M., Russo, D., & Damante, G. (2012) · Journal of Molecular Endocrinology · doi:10.1530/jme-11-0063 · Cited by 11

Evaluation of MEDAG gene expression in papillary thyroid microcarcinoma: associations with histological features, regional lymph node metastasis and prognosis

Song, Y., Fu, L., Li, H.-T., & Qiu, X. (2019) · Scientific Reports · doi:10.1038/s41598-019-41701-4 · Cited by 11

Is There a Treatment Advantage When Paclitaxel and Lovastatin Are Combined to Dose Anaplastic Thyroid Carcinoma Cell Lines?

Chung, Y. S., Cho, S., Ryou, H. J., Jee, H., Choi, J. Y., Yoon, K., Choi, H., Lee, K. E., Suh, Y. J., Oh, S. K., et al. (2011) · Thyroid · doi:10.1089/thy.2010.0304 · Cited by 11

Thyroid Cancer Cell Line Misidentification: An Update

Schweppe, R. E. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-4182 · Cited by 11

Trace Amine-Associated Receptor 1 Trafficking to Cilia of Thyroid Epithelial Cells

Qatato, M., Venugopalan, V., Al-Hashimi, A., Rehders, M., Valentine, A. D., Hein, Z., Dallto, U., Springer, S., & Brix, K. (2021) · Cells · doi:10.3390/cells10061518 · Cited by 10

CDK4 phosphorylation status and rational use for combining CDK4/6 and BRAF/MEK inhibition in advanced thyroid carcinomas

Pita, J. M. G., Raspé, E., Coulonval, K., Decaussin‐Petrucci, M., Tarabichi, M., Dom, G., Libert, F., Craciun, L., Andry, G., Wicquart, L., et al. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1247542 · Cited by 12

MiRNA Expression May Account for Chronic but Not for Acute Regulation of mRNA Expression in Human Thyroid Tumor Models

Floor, S. L., Hébrant, A., Pita, J. M. G., Saiselet, M., Trésallet, C., Libert, F., Andry, G., Dumont, J. E., van Staveren, W. C. G., & Maenhaut, C. (2014) · PLoS ONE · doi:10.1371/journal.pone.0111581 · Cited by 10

Targeted Treatment Options of Recurrent Radioactive Iodine Refractory Hürthle Cell Cancer

Aydemirli, M. D., Corver, W. E., Beuk, R., Roepman, P., Solleveld‐Westerink, N., van Wezel, T., Kapiteijn, E., & Morreau, H. M. (2019) · Cancers · doi:10.3390/cancers11081185 · Cited by 10

Estradiol-mediated tumor neo-vascularization

Rajoria, S., Suriano, R., Wilson, Y. L., George, A. L., Geliebter, J., Schantz, S. P., & Tiwari, R. K. (2011) · Oncology Letters · doi:10.3892/ol.2011.283 · Cited by 10

Involvement of Nrf2 in proteasome inhibition-mediated induction of ORP150 in thyroid cancer cells

Zong, Z., Du, Z., Zhang, H.-Y., Li, C., An, M., Li, S., Yao, H.-B., & Wang, H. (2015) · Oncotarget · doi:10.18632/oncotarget.6636 · Cited by 10

Thyrospheres from B-CPAP Cell Line with BRAF and TERT Promoter Mutations have Different Functional and Molecular Features than Parental Cells

Caria, P., Pillai, R., Dettori, T., Frau, D. V., Zavattari, P., Riva, G., Romano, G., Pani, F., Bentivegna, A., Giovannoni, R., et al. (2017) · Journal of Cancer · doi:10.7150/jca.18855 · Cited by 10

Genetic-Targeted Therapy of Thyroid Cancer: A Real Promise

Xing, M. (2009) · Thyroid · doi:10.1089/thy.2009.1583 · Cited by 10

p21 participates in the regulation of anaplastic thyroid cancer cell proliferation by miR-146b

Wang, S., Chen, Y., & Bai, Y. (2016) · Oncology Letters · doi:10.3892/ol.2016.4874 · Cited by 9

Efficacy and Biomarker Analysis of Adavosertib in Differentiated Thyroid Cancer

Lu, Y., Wu, M., Lee, Y.-Y., Chou, T., Wong, R. J., & Lin, S. (2021) · Cancers · doi:10.3390/cancers13143487 · Cited by 9

Spry2 expression correlates with BRAF mutation in thyroid cancer

Xu, L., Zhou, J. L., Cohen, M., Bar‐Sagi, D., & Patel, K. N. (2010) · Surgery · doi:10.1016/j.surg.2010.09.028 · Cited by 9

Inhibition of p21 and Akt Potentiates SU6656-Induced Caspase-Independent Cell Death in FRO Anaplastic Thyroid Carcinoma Cells

Kim, S., Kang, J., Kim, C. G., Ihm, S., Choi, M. G., Yoo, H., & Lee, S. (2013) · Hormone and Metabolic Research · doi:10.1055/s-0033-1333716 · Cited by 9

Characterization of metabolic reprogramming by metabolomics in the oncocytic thyroid cancer cell line XTC.UC1

Kurashige, T., Shimamura, M. I., Hamada, K., Matsuse, M., Mitsutake, N., & Nagayama, Y. (2023) · Scientific Reports · doi:10.1038/s41598-023-27461-2 · Cited by 10

Misidentification of Putative Medullary Thyroid Cancer Cell Lines RO-H85-1 and RO-D81-1

Dadon, T., Ball, D. W., & Nelkin, B. D. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-4181 · Cited by 9

An Epistatic Interaction between the PAX8 and STK17B Genes in Papillary Thyroid Cancer Susceptibility

Landa, I., Boullosa, C., Inglada‐Pérez, L., Sastre-Perona, A., Pastor, S., Velázquez, A., Mančíková, V., Ruiz‐Llorente, S., Schiavi, F., Marcos, R., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0074765 · Cited by 9

Fibromodulin deficiency reduces collagen structural network but not glycosaminoglycan content in a syngeneic model of colon carcinoma

Olsson, P. O., Kalamajski, S., Maccarana, M., Oldberg, Å., & Rubin, K. (2017) · PLoS ONE · doi:10.1371/journal.pone.0182973 · Cited by 9

Genetic variants in the histone methylation and acetylation pathway and their risks in eight types of cancers

Fu, L. N., Tan, J., Chen, Y., & Fang, J. (2018) · Journal of Digestive Diseases · doi:10.1111/1751-2980.12574 · Cited by 9

Emerging Therapies in Sight for the Fight against Dedifferentiated Thyroid Cancer

Benvenga, S. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2799 · Cited by 9

Expression of miR-31-5p affects growth, migration and invasiveness of papillary thyroid cancer cells

Maggisano, V., Capriglione, F., Verrienti, A., Celano, M., Sponziello, M., Pecce, V., Russo, D., Durante, C., & Bulotta, S. (2022) · Endocrine · doi:10.1007/s12020-022-03267-6 · Cited by 8

Dual-imaging nanoparticles based on surface-modified magnetic nanoparticles and biodegradable photoluminescent polymers

Pandey, N., Iyer, P., Kadapure, T. D., Yang, J. Y., Nguyen, K. T., & Wadajkar, A. S. (2025) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2025.1558817 · Cited by 8

5-Aza-2′-Deoxycytidine Has Minor Effects on Differentiation in Human Thyroid Cancer Cell Lines, But Modulates Genes That Are Involved in Adaptation In Vitro

Dom, G., Galdo, V. C., Tarabichi, M., Tomás, G., Hébrant, A., Andry, G., Martelar, V. D., Libert, F., Leteurtre, E., Dumont, J. E., et al. (2012) · Thyroid · doi:10.1089/thy.2012.0388 · Cited by 8

Similarities and Differences in Gene Expression Networks Between the Breast Cancer Cell Line Michigan Cancer Foundation-7 and Invasive Human Breast Cancer Tissues

Tran, V. P., Kim, R., Maertens, M., Härtung, T., & Maertens, A. (2021) · Frontiers in Artificial Intelligence · doi:10.3389/frai.2021.674370 · Cited by 8

Effect of hypoxia‑HIF‑1α‑periostin axis in thyroid cancer

Yang, Y., Wu, J., Zhu, H., Shi, X., Liu, J., Li, Y., & Wang, M. (2024) · Oncology Reports · doi:10.3892/or.2024.8716 · Cited by 8

Evaluation of Lentiviral-Mediated Expression of Sodium Iodide Symporter in Anaplastic Thyroid Cancer and the Efficacy of In Vivo Imaging and Therapy

Ke, C., Hsieh, Y.-J., Hwu, L., Wang, F.-H., Chen, F., Chu, L.-S., Lee, O. K., Chi, C., Lee, C.-H., & Liu, R.-S. (2011) · Journal of Oncology · doi:10.1155/2011/178967 · Cited by 8

Effects of roniciclib in preclinical models of anaplastic thyroid cancer

Lin, S., Lin, J., Hsueh, C., Chou, T., & Wong, R. J. (2017) · Oncotarget · doi:10.18632/oncotarget.19092 · Cited by 8

Genetic Characterization of Rat Hepatic Stellate Cell Line PAV-1

Gäberlein, K., Schröder, S. K., Nanda, I., Steinlein, C., Haaf, T., Buhl, E. M., Sauvant, P., Sapin, V., Abergel, A., & Weiskirchen, R. (2023) · Cells · doi:10.3390/cells12121603 · Cited by 8

8-Cl-Adenosine Inhibits Proliferation and Causes Apoptosis in B-Lymphocytes via Protein Kinase A-Dependent and Independent Effects: Implications for Treatment of Carney Complex-Associated Tumors

Robinson-White, A. J., Bossis, I., Hsiao, H., Nesterova, M., Leitner, W. W., & Stratakis, C. A. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0759 · Cited by 8

Mysie modele raka brodawkowatego tarczycy — krótki przegląd

Rusinek, D., Krajewska, J., & Jarząb, M. (2016) · Endokrynologia Polska · doi:10.5603/ep.a2016.0042 · Cited by 8

PATZ1 knockdown enhances malignant phenotype in thyroid epithelial follicular cells and thyroid cancer cells

Iesato, A., Nakamura, T., Izumi, H., Uehara, T., & Ito, K. (2017) · Oncotarget · doi:10.18632/oncotarget.19787 · Cited by 8

The nuclear factor kappa-B signaling pathway as a therapeutic target against thyroid cancers

Li, X., Abdel‐Mageed, A. B., Mondal, D., & Kandil, E. H. (2012) · Thyroid · doi:10.1089/thy.2012-0237 · Cited by 8

Antineoplastic Agents. 548. Synthesis of Iodo- and Diiodocombstatin Phosphate Prodrugs

Pettit, G. R., Rosenberg, H. J., Dixon, R., KNIGHT, J. C., Hamel, E., Chapuis, J., Pettit, R. K., Hogan, F., Sumner, B., Ain, K. B., et al. (2012) · Journal of Natural Products · doi:10.1021/np200797x · Cited by 7

Klotho Inhibits Proliferation in a RET Fusion Model of Papillary Thyroid Cancer by Regulating the Wnt/β-Catenin Pathway

Wu, Q., Jiang, L., Wu, J., Dong, H., & Zhao, Y. (2021) · Cancer Management and Research · doi:10.2147/cmar.s295086 · Cited by 7

The effects of Aurora Kinase inhibition on thyroid cancer growth and sensitivity to MAPK-directed therapies

Hicks, H. M., Nassar, V. L., Lund, J., Rose, M. M., & Schweppe, R. E. (2024) · Cancer Biology & Therapy · doi:10.1080/15384047.2024.2332000 · Cited by 7

Real-time imaging of tumor progression in a fluorescent orthotopic mouse model of thyroid cancer.

Cao, H. S. T., Kaushal, S., Snyder, C. S., Ongkeko, W. M., Hoffman, R. M., & Bouvet, M. (2010) · PubMed · Cited by 7

Destabilizing RET in targeted treatment of thyroid cancers

Gild, M. L., Bullock, M., Pon, C. K., Robinson, B. G., & Clifton-Bligh, R. J. (2015) · Endocrine Connections · doi:10.1530/ec-15-0098 · Cited by 7

STR Profiling of Human Cell Lines: Challenges and Possible Solutions to the Growing Problem

Shewale, J. G. (2011) · Journal of Forensic Research · doi:10.4172/2157-7145.s2-005 · Cited by 7

Biological Evaluation of a Fluorescent-Imaging Agent for Medullary Thyroid Cancer in an Orthotopic Model

Rossfeld, K. K., Justiniano, S. E., Ding, H., Gong, L., Kothandaraman, S., Sawant, D. B., Saji, M., Wright, C., Kirschner, L. S., Ringel, M. D., et al. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-00573 · Cited by 7

Herbimycin A inhibits cell growth with reversal of epithelial–mesenchymal transition in anaplastic thyroid carcinoma cells

Kim, S. H., Kang, J. G., Kim, C. S., Ihm, S., Choi, M. G., Yoo, H. J., & Lee, S. J. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.11.018 · Cited by 7

The Molecular Effect of Diagnostic Absorbed Doses from 131I on Papillary Thyroid Cancer Cells In Vitro

Stasiołek, M., Adamczewski, Z., Śliwka, P. W., Puła, B., Karwowski, B. T., Merecz-Sadowska, A., Dedecjus, M., & Lewiñski, A. (2017) · Molecules · doi:10.3390/molecules22060993 · Cited by 7

Selective inhibition of DNA ligase IV provides additional efficacy to the treatment of anaplastic thyroid cancer

Sriramareddy, S. N., Jamakhani, M., Vilanova, L. T., Brossel, H., Staumont, B., & Hamaïdia, M. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1323313 · Cited by 6

Circular RNAs and thyroid cancer: Closed molecules, open possibilities

Shifman, B. M., Platonova, N. M., Vasilyev, E., Магомедовна, А. Ф., & Александровна, К. В. (2022) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2022.103662 · Cited by 6

Therapeutic inhibition of ATR in differentiated thyroid cancer

Lin, S., Lee, Y.-Y., Wu, M., Lu, Y., Yeh, C., Chen, W., Chou, T., & Wong, R. J. (2023) · Endocrine Related Cancer · doi:10.1530/erc-23-0142 · Cited by 6

Microsatellite Instable and Microsatellite Stable Primary Endometrial Carcinoma Cells and Their Subcutaneous and Orthotopic Xenografts Recapitulate the Characteristics of the Corresponding Primary Tumor

Schrauwen, S., Coenegrachts, L., Depreeuw, J., Luyten, C., Verbist, G., Debruyne, D., Vergote, I. B., Lambrechts, D., & Amant, F. C. (2015) · International Journal of Gynecological Cancer · doi:10.1097/igc.0000000000000363 · Cited by 6

Challenges and Advances in the Development of Cell Lines and Xenografts

Schweppe, R. E., & Korch, C. T. (2018) · Advances in Molecular Pathology · doi:10.1016/j.yamp.2018.07.004 · Cited by 6

Therapeutic inhibition of polo‐like kinases in anaplastic thyroid cancer

Lin, S., Yeh, C., Huang, Y., Chou, T., & Wong, R. J. (2020) · Cancer Science · doi:10.1111/cas.14769 · Cited by 6

p90RSK Regulates p53 Pathway by MDM2 Phosphorylation in Thyroid Tumors

Maietta, I., Peschio, F. D., Buonocore, P., Viscusi, E., Laudati, S., Iannaci, G., Minopoli, M., Motti, M. L., & Falco, V. D. (2022) · Cancers · doi:10.3390/cancers15010121 · Cited by 6

Expression of exogenous proteins and short hairpin RNAs in human primary thyrocytes

Bravo, S. B., García-Rendueles, M. E. R., Pérez-Romero, S., Cameselle‐Teijeiro, J., Rodrigues, J. S., Barreiro, F. J. J., & Álvarez, C. V. (2010) · Analytical Biochemistry · doi:10.1016/j.ab.2010.01.034 · Cited by 6

Illuminating the role of lncRNAs ROR and MALAT1 in cancer stemness state of anaplastic thyroid cancer: An exploratory study

Mahdiannasser, M., Khazaei, S., Rahnama, M. A., Zomorrod, M. S., Soutodeh, F., Parichehreh-Dizaji, S., Rakhsh-Khorshid, H., Samimi, H., & Haghpanah, V. (2023) · Non-coding RNA Research · doi:10.1016/j.ncrna.2023.05.006 · Cited by 5

Mouse Models to Examine Differentiated Thyroid Cancer Pathogenesis: Recent Updates

Choi, H. R., & Kim, K. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241311138 · Cited by 5

PDPR Gene Variants Predisposing to Papillary Thyroid Cancer

Brock, P. L., Sévigny, M., Liyanarachchi, S., Comiskey, D. F., Li, W., Saarinen, S., Yilmaz, A. S., Nieminen, A. I., Ringel, M. D., Peltomäki, P., et al. (2023) · Thyroid · doi:10.1089/thy.2023.0560 · Cited by 5

Human Cell Line Authentication: The Critical First Step in Any Project Using Human Cell Lines

McLaren, R. S., Reid, Y. A., & Storts, D. R. (2012) · Methods in molecular biology · doi:10.1007/978-1-62703-230-8_21 · Cited by 5

Characterization of human follicular thyroid cancer cell lines in preclinical mouse models

Reeb, A. N., Ziegler, A. M., & Lin, R.-Y. (2016) · Endocrine Connections · doi:10.1530/ec-15-0114 · Cited by 5

Dysadherin specific drug conjugates for the treatment of thyroid cancers with aggressive phenotypes

Jang, S., Yu, X.-M., Montemayor, C., Ahmed, K., Weinlander, E. J., Lloyd, R. V., Dammalapati, A., Marshall, D., Prudent, J. R., & Chen, H. (2017) · Oncotarget · doi:10.18632/oncotarget.14904 · Cited by 5

Historical and Current Methods for Detecting Interspecies and Intraspecies Cell Mixtures and Thereby Assuring Cell Line Purity

Nims, R. W. (2018) · Advances in Molecular Pathology · doi:10.1016/j.yamp.2018.07.005 · Cited by 5

Suppression of Calcium Entry Modulates the Expression of TRβ1 and Runx2 in Thyroid Cancer Cells, Two Transcription Factors That Regulate Invasion, Proliferation and Thyroid-Specific Protein Levels

Asghar, M. Y., Knuutinen, T., Holm, E., Nordström, T., Nguyen, V. D., Zhou, Y., & Törnquist, K. (2022) · Cancers · doi:10.3390/cancers14235838 · Cited by 5

Detecting and Quantitating Low Fraction DNA Variants with Low-Depth SequencingPreprint

Song, P., Chen, S. X., Yan, Y. H., Pinto, A., Cheng, L. Y., Dai, P., Patel, A. A., & Zhang, D. Y. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.04.26.061747 · Cited by 5

Genetic Insights into the Economic Toll of Cell Line Misidentification: A Comprehensive Review

Weiskirchen, R. (2026) · Medical Sciences · doi:10.3390/medsci14010025 · Cited by 4

Toward In Vitro Epigenetic Drug Design for Thyroid Cancer: The Promise of PF-03814735, an Aurora Kinase Inhibitor

Dalva-Aydemir, S., Akyerli, C. B., Yüksel, Ş., Karakoyun, H. K., & Yakicier, M. C. (2019) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2019.0050 · Cited by 4

RNA Profile of Cell Bodies and Exosomes Released by Tumorigenic and Non-Tumorigenic Thyroid Cells

Maggisano, V., Capriglione, F., Mio, C., Bulotta, S., Damante, G., Russo, D., & Celano, M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25031407 · Cited by 4

Exploring the Therapeutic Potential of Extracellular Vesicles Derived from Human Immature Dental Pulp Cells on Papillary Thyroid Cancer

Teixeira, M. R., Alievi, A. L., da Costa, V. R., Kerkis, I., & Araldi, R. P. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25158178 · Cited by 4

Evaluation of microRNA expression in head and neck squamous cell carcinoma cell lines and in primary culture of oral keratinocytes

Andreghetto, F. M., Klingbeil, M. F. G., Soares, R. M., Sitnik, R., Júnior, D. D. S. P., Mathor, M. B., Nunes, F. D., & Severino, P. (2011) · Einstein (São Paulo) · doi:10.1590/s1679-45082011ao2149 · Cited by 4

SPRY4 as a Potential Mediator of the Anti-Tumoral Role of Macrophages in Anaplastic Thyroid Cancer Cells

Pinto, A. T., Pojo, M., Rodrigues, R., Sousa, D. P., Matthiesen, R., Carvalho, A. S., Beck, H. C., Pires, C., Eduardo, R., Simões‐Pereira, J., et al. (2023) · Cancers · doi:10.3390/cancers15174387 · Cited by 4

Honokiol Suppresses Cell Proliferation and Tumor Migration through ROS in Human Anaplastic Thyroid Cancer Cells

Liao, K., Lee, Y., Chao, W.-Y., Huang, Y.-J., Chung, H.-C., Chen, S., Li, Y., Zhao, P., & Chang, H. (2024) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/0118715303295608240408082523 · Cited by 4

Relaxin-2 is a novel biomarker for differentiated thyroid carcinoma in humans

Kotwal, A., Simpson, R. L., Whiteman, N., Swanson, B. J., Yuil-Valdes, A. G., Fitch, M., Nguyen, J., Elhag, S., Shats, O., Goldner, W. S., et al. (2024) · Biochemical Pharmacology · doi:10.1016/j.bcp.2024.116323 · Cited by 4

Localization of CaSR Antagonists in CaSR-expressing Medullary Thyroid Cancer

Ding, H., Yusof, A. M., Kothandaraman, S., Saji, M., Wang, C., Kumar, K., Milum, K., Carleton, M., Pan, X. J., Ringel, M. D., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1756 · Cited by 4

Prevalence and Prevention of Reproducibility Deficiencies in Life Sciences Research: Large-Scale Meta-Analyses

Mansour, N. M., Balas, E. A., Yang, F. M., & Vernon, M. (2020) · Medical Science Monitor · doi:10.12659/msm.922016 · Cited by 4

Defining the In Vivo Role of mTORC1 in Thyrocytes by Studying the TSC2 Conditional Knockout Mouse Model

Rossetti, C., Alves, B., Peçanha, F. L., Franco, A., Nosé, V., Carneiro, E. M., Lew, J. L., Bernal-Mizrachi, E., & Werneck-de-Castro, J. P. (2023) · bioRxiv · doi:10.1089/thy.2024.0053 · Cited by 3

Focal adhesion kinase promotes ribosome biogenesis to drive advanced thyroid cancer cell growth and survival

Kellett, M. D., Sharma, V., Sherlock, M. E., Pugazhenthi, U., Rose, M. M., Joshi, M. U., Dzieciątkowska, M., Nguyen, V., Reigan, P., Hansen, K. C., et al. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1252544 · Cited by 3

Targeting Ataxia Telangiectasia-Mutated and Rad3-Related for Anaplastic Thyroid Cancer

Lin, S., Hsueh, C., Chen, W., Chou, T., & Wong, R. J. (2025) · Cancers · doi:10.3390/cancers17030359 · Cited by 3

Effects of sorafenib and an adenylyl cyclase activator on in vitro growth of well-differentiated thyroid cancer cells

Sawa, A., Chiba, T., Ishii, J., Yamamoto, H., Hara, H., & Kamma, H. (2017) · Endocrine Journal · doi:10.1507/endocrj.ej16-0525 · Cited by 3

MicroRNAs as regulatory molecules in cancer: a focus on models defining miRNA functions

Abba, M. L., & Allgayer, H. (2009) · Drug Discovery Today Disease Models · doi:10.1016/j.ddmod.2009.01.002 · Cited by 3

Innovative In Vitro Chemo-Hormonal Drug Therapy for Refractory Thyroid Carcinomas

Sung, T., Choi, S. H., Lee, J. M., Jeong, J. J., Kang, S., & Chung, W. Y. (2012) · Journal of Korean Medical Science · doi:10.3346/jkms.2012.27.7.729 · Cited by 3

Letter to the Editor: Antiproliferation and Redifferentiation in Thyroid Cancer Cell Line by Polyphenol Phytochemicals

Kim, T. Y. (2011) · Journal of Korean Medical Science · doi:10.3346/jkms.2011.26.10.1397 · Cited by 3

ER Stress Is Associated with a “Mesenchymal Drift” in an Anaplastic Thyroid Carcinoma Cell Line

Lofrumento, D. D., Miraglia, A., Treglia, A. S., Nuccio, F. D., Nicolardi, G., Garbi, C., & Jeso, B. D. (2025) · Cancers · doi:10.3390/cancers17213534 · Cited by 2

Thyroid Cancer Cell Line Misidentification: An Update

Schweppe, R. E. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-4182 · Cited by 11

The Author Response Antiproliferation and Redifferentiation in Thyroid Cancer Cell

Phytochemicals, L. P., Kang, H. J., Youn, Y.-K., Hong, M.-K., & Kim, L. S. (2013)

The Author Response: Antiproliferation and Redifferentiation in Thyroid Cancer Cell Line by Polyphenol Phytochemicals

Kang, H. J., Youn, Y., Hong, M.-K., & Kim, L. S. (2011) · Journal of Korean Medical Science · doi:10.3346/jkms.2011.26.10.1398 · Cited by 2

Methodology, Criteria, and Characterization of Patient-Matched Thyroid Cell Lines and Patient-Derived Tumor Xenografts

Marlow, L. A., Rohl, S. D., Miller, J. L., Knauf, J. A., Fagin, J. A., Ryder, M. M., Milosevic, D., Netzel, B. C., Grebe, S. K. G., Reddi, H. V., et al. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-01845 · Cited by 19

Conventional and molecular cytogenetics of human non-medullary thyroid carcinoma: characterization of eight cell line models and review of the literature on clinical samples

Ribeiro, F. R., Meireles, A. M., Rocha, A. S., & Teixeira, M. R. (2008) · BMC Cancer · doi:10.1186/1471-2407-8-371 · Cited by 41